Norwich Pharmacal Company v. Sterling Drug, Inc.

271 F.2d 569, 123 U.S.P.Q. (BNA) 372, 1959 U.S. App. LEXIS 5394
CourtCourt of Appeals for the Second Circuit
DecidedNovember 9, 1959
Docket290, Docket 25488
StatusPublished
Cited by93 cases

This text of 271 F.2d 569 (Norwich Pharmacal Company v. Sterling Drug, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Norwich Pharmacal Company v. Sterling Drug, Inc., 271 F.2d 569, 123 U.S.P.Q. (BNA) 372, 1959 U.S. App. LEXIS 5394 (2d Cir. 1959).

Opinion

MOORE, Circuit Judge.

Plaintiff, a New York corporation, and defendant, a Delaware corporation, both engage in the manufacture of drugs and pharmaceutical products. For several years, plaintiff has marketed a pink liquid preparation, “Pepto-Bismol,” designed to remedy minor stomach disorders. With the aid of extensive advertising, the sales of Pepto-Bismol have steadily increased; by 1955 plaintiff’s product was nationally recognized and was undoubtedly the leader in the field of stomach assuagement. Defendant in 1955 introduced a comparable proprietary medicine, “Pepsamar,” which was virtually identical to Pepto-Bismol as regards chemistry, color and flavor but dissimilar as regards container and label. The evidence indicates that defendant’s decision to manufacture Pepsamar was prompted in part by retaliatory as well as competitive motives, 1 that defendant previously investigated plaintiff’s sales and advertising techniques, and that the pink color was emphasized in the advertising of Pepsamar.

Upon the theory that secondary meaning is no longer required in New York 2 to sustain a finding of unfair competition and the fact that pink is a nonfunctional attribute of plaintiff’s product which defendant intentionally copied, the court below * permanently enjoined defendant from simulating the pink col- or of Pepto-Bismol in its product Pepsamar and manufacturing and selling such a product. This injunctive direction was immediately qualified by a proviso that it should not apply so long as the pink Pepsamar were sold in blue bottles or bottles of any other color which would “effectively conceal the pink color of the Pepsamar contained therein.” Defendant was also enjoined “from describing its Pepsamar as pink in color, by words or illustrations, in any advertising of Pepsamar or any promotional material * * *.” From this judgment defendant appeals.

Distaste for sharp or unethical business practices has often caused the *571 courts to lose sight of the fundamental consideration in the law of unfair competition — protection of the public. 3 Added to this standard is a developing body of law which pertains only to business conduct, namely, that a court of equity will restrain such practices as constitute palming off, actual deception or appropriation of another’s property. Viewed against this background, misunderstanding as to the essential elements of an unfair competition cause of action may well be dissipated.

Consumer protection has been limited to the prevention of confusion, i. e., the customer should not mistake defendant’s article for that of plaintiff or believe that it derives from the same source as plaintiff’s goods. It is in such context that secondary meaning inheres, and when this special significance attaches in the public mind to the non-funetional attributes of its wares, a plaintiff need further establish merely the likelihood of confusion — or a defendant may rebut the effect of secondary meaning by proving that confusion is unlikely. Restatement of Torts, Sec. 741 (1938), Lucien Lelong, Inc. v. Lander Co., 2 Cir., 1947, 164 F.2d 395.

In cases where the New York courts have occasionally granted relief without proof of secondary meaning, one of the aforementioned predatory practices was established: In Santa’s Workshop, Inc. v. Sterling, 3d Dept. 1956, 2 A.D.2d 262, 153 N.Y.S.2d 839, it was palming off; in Oneida, Ltd. v. National Silver Co., Sup.Ct.Madison Co.1940, 25 N.Y.S.2d 271 and Avon Periodicals v. Ziff-Davis Publishing Co., 1st Dept. 1953, 282 App.Div. 200, 122 N.Y.S.2d 92, it was actual deception; in Dior v. Milton, Sup.Ct.N.Y.Co.1956, 9 Misc.2d 425, 155 N.Y.S.2d 443, affirmed 1st Dept. 1956, 2 A.D.2d 878, 156 N.Y.S.2d 996, and Metropolitan Opera Ass’n v. Wag ner-Nichols Record Corp., Sup.Ct.N.Y. Co.1950, 199 Misc. 786, 101 N.Y.S.2d 483, affirmed 1st Dept. 1951, 279 App. Div. 632, 107 N.Y.S.2d 795, it was violation of plaintiff’s property rights. 4 The federal decisions fall into the same pattern: Artype, Incorporated v. Zappulla, 2 Cir., 1956, 228 F.2d 695, and Flint Co. v. Oleet Jewelry Manufacturing Co., D.C.S.D.N.Y.1955, 133 F.Supp. 459 (actual deception); Upjohn Company v. Schwartz, 2 Cir., 1957, 246 F.2d 254 (palming off); International News Service v. Associated Press, 1918, 248 U.S. 215, 39 S.Ct. 68, 63 L.Ed. 211 (appropriation of property rights). Hence, the first comer may prevail if he proves secondary meaning plus likelihood of confusion on the one hand or that the second comer has indulged in one of the proscribed practices which equity will enjoin, on the other. The facts here neatly illustrate application of this rule.

Plaintiff, while correctly asserting that proof of secondary meaning is not always a prerequisite to securing relief, must fit its case into one of the remaining categories. This it fails to do. There is no evidence of an attempt or intent to pass off Pepsamar as Pepto-Bismol or to divert plaintiff’s customers by means of deception. Defendant’s finished product is quite dissimilar from that of plaintiff, not only in most of the details, e. g., shape of the bottle, color of the label and appearance of the cap, but also in the overall effect upon the observer. 5 To the prospective purchaser the names on both bottles are in type large enough to be distinguished at a reading distance of over twenty feet. The label covers most of the bottle. Pepto-Bismol’s label is yellow with large red letters; Pepsamar’s is white with even larger blue letters. Indeed, it stretches credulity to imagine a purchaser confusing these disparate articles. Moreover, *572 the essential distinction in this area of the law, overlooked by the court below, is the difference between a deliberate attempt to deceive and a deliberate attempt to compete. Absent confusion, imitation of certain successful features in another’s product is not unlawful and to that extent a “free ride” is permitted. Charles D. Briddell, Inc. v. Alglobe Trading Corporation, 2 Cir., 1952, 194 F.2d 416.

Similarly, there is here no violation of plaintiff’s property rights, 6 notwithstanding the fact that defendant investigated and presumably utilized some of the Pepto-Bismol marketing techniques. Such skills cannot be cornered; the competitor must only refrain from using them in such a way that the public is misled.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

George Basch Co. v. Blue Coral, Inc.
968 F.2d 1532 (Second Circuit, 1992)
The George Basch Co., Inc. v. Blue Coral, Inc.
968 F.2d 1532 (Second Circuit, 1992)
Laureyssens v. Idea Group
964 F.2d 131 (Second Circuit, 1992)
Laureyssens v. Idea Group, Inc.
964 F.2d 131 (Second Circuit, 1992)
In Re Owens-Corning Fiberglas Corporation
774 F.2d 1116 (Federal Circuit, 1985)
Gemveto Jewelry Co. v. Jeff Cooper, Inc.
613 F. Supp. 1052 (S.D. New York, 1985)
S.C. Johnson & Son, Inc. v. Carter-Wallace, Inc.
614 F. Supp. 1278 (S.D. New York, 1985)
Crazy Eddie, Inc. v. Lois Pitts Gershon, Inc.
600 F. Supp. 537 (S.D. New York, 1984)
Universal City Studios, Inc. v. Nintendo Co.
578 F. Supp. 911 (S.D. New York, 1983)
Plains Tire & Battery Co. v. Plains a to Z Tire Co.
622 P.2d 917 (Wyoming Supreme Court, 1981)
Sk&f, Co. v. Premo Pharmaceutical Laboratories, Inc.
625 F.2d 1055 (Third Circuit, 1980)
Ives Laboratories, Inc. v. Darby Drug Co.
601 F.2d 631 (Second Circuit, 1979)
Ives Laboratories, Inc. v. Darby Drug Co., Inc.
455 F. Supp. 939 (E.D. New York, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
271 F.2d 569, 123 U.S.P.Q. (BNA) 372, 1959 U.S. App. LEXIS 5394, Counsel Stack Legal Research, https://law.counselstack.com/opinion/norwich-pharmacal-company-v-sterling-drug-inc-ca2-1959.